201 related articles for article (PubMed ID: 15743920)
1. Characterization of the T-cell response in a patient with phenindione hypersensitivity.
Naisbitt DJ; Farrell J; Chamberlain PJ; Hopkins JE; Berry NG; Pirmohamed M; Park BK
J Pharmacol Exp Ther; 2005 Jun; 313(3):1058-65. PubMed ID: 15743920
[TBL] [Abstract][Full Text] [Related]
2. Generation and characterization of antigen-specific CD4+, CD8+, and CD4+CD8+ T-cell clones from patients with carbamazepine hypersensitivity.
Wu Y; Farrell J; Pirmohamed M; Park BK; Naisbitt DJ
J Allergy Clin Immunol; 2007 Apr; 119(4):973-81. PubMed ID: 17320939
[TBL] [Abstract][Full Text] [Related]
3. T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity.
Schmid DA; Depta JP; Pichler WJ
Clin Exp Allergy; 2006 Jan; 36(1):59-69. PubMed ID: 16393267
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of human T cells with sulfonamides and sulfonamide metabolites.
Castrejon JL; Berry N; El-Ghaiesh S; Gerber B; Pichler WJ; Park BK; Naisbitt DJ
J Allergy Clin Immunol; 2010 Feb; 125(2):411-418.e4. PubMed ID: 20159253
[TBL] [Abstract][Full Text] [Related]
5. Delayed drug hypersensitivity reactions - new concepts.
Posadas SJ; Pichler WJ
Clin Exp Allergy; 2007 Jul; 37(7):989-99. PubMed ID: 17581192
[TBL] [Abstract][Full Text] [Related]
6. Trimethoprim stimulates T-cells through metabolism-dependent and -independent pathways.
El-Ghaiesh S; Sanderson JP; Farrell J; Lavergne SN; Syn WK; Pirmohamed M; Park BK; Naisbitt DJ
Chem Res Toxicol; 2011 Jun; 24(6):791-3. PubMed ID: 21491947
[TBL] [Abstract][Full Text] [Related]
7. Characterization of drug-specific T cells in lamotrigine hypersensitivity.
Naisbitt DJ; Farrell J; Wong G; Depta JP; Dodd CC; Hopkins JE; Gibney CA; Chadwick DW; Pichler WJ; Pirmohamed M; Park BK
J Allergy Clin Immunol; 2003 Jun; 111(6):1393-403. PubMed ID: 12789244
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic diversity in delayed drug hypersensitivity: an immunologic explanation.
Meth MJ; Sperber KE
Mt Sinai J Med; 2006 Sep; 73(5):769-76. PubMed ID: 17008937
[TBL] [Abstract][Full Text] [Related]
9. Homotypic T-cell/T-cell interaction induces T-cell activation, proliferation, and differentiation.
Ramming A; Thümmler K; Schulze-Koops H; Skapenko A
Hum Immunol; 2009 Nov; 70(11):873-81. PubMed ID: 19682527
[TBL] [Abstract][Full Text] [Related]
10. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A
Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
[TBL] [Abstract][Full Text] [Related]
11. Long-lasting reactivity and high frequency of drug-specific T cells after severe systemic drug hypersensitivity reactions.
Beeler A; Engler O; Gerber BO; Pichler WJ
J Allergy Clin Immunol; 2006 Feb; 117(2):455-62. PubMed ID: 16461148
[TBL] [Abstract][Full Text] [Related]
12. Activation of T cells by carbamazepine and carbamazepine metabolites.
Wu Y; Sanderson JP; Farrell J; Drummond NS; Hanson A; Bowkett E; Berry N; Stachulski AV; Clarke SE; Pichler WJ; Pirmohamed M; Park BK; Naisbitt DJ
J Allergy Clin Immunol; 2006 Jul; 118(1):233-41. PubMed ID: 16815161
[TBL] [Abstract][Full Text] [Related]
13. Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells.
Kobayashi H; Nagato T; Takahara M; Sato K; Kimura S; Aoki N; Azumi M; Tateno M; Harabuchi Y; Celis E
Cancer Res; 2008 Feb; 68(3):901-8. PubMed ID: 18245493
[TBL] [Abstract][Full Text] [Related]
14. Potential involvement of dendritic cells in delayed-type hypersensitivity reactions to beta-lactams.
Rodriguez-Pena R; Lopez S; Mayorga C; Antunez C; Fernandez TD; Torres MJ; Blanca M
J Allergy Clin Immunol; 2006 Oct; 118(4):949-56. PubMed ID: 17030251
[TBL] [Abstract][Full Text] [Related]
15. Lymphocyte proliferation response in patients with delayed hypersensitivity reactions to heparins.
Lopez S; Torres MJ; Rodríguez-Pena R; Blanca-Lopez N; Fernandez TD; Antunez C; Canto G; de Luque V; Mayorga C
Br J Dermatol; 2009 Feb; 160(2):259-65. PubMed ID: 18945304
[TBL] [Abstract][Full Text] [Related]
16. CD69 upregulation on T cells as an in vitro marker for delayed-type drug hypersensitivity.
Beeler A; Zaccaria L; Kawabata T; Gerber BO; Pichler WJ
Allergy; 2008 Feb; 63(2):181-8. PubMed ID: 18005225
[TBL] [Abstract][Full Text] [Related]
17. Drug-induced hypersensitivity syndrome associated with cytomegalovirus reactivation: immunological characterization of pathogenic T cells.
Hashizume H; Takigawa M
Acta Derm Venereol; 2005; 85(1):47-50. PubMed ID: 15848991
[TBL] [Abstract][Full Text] [Related]
18. Detection and quantification of drug-specific T cells in penicillin allergy.
Rozieres A; Hennino A; Rodet K; Gutowski MC; Gunera-Saad N; Berard F; Cozon G; Bienvenu J; Nicolas JF
Allergy; 2009 Apr; 64(4):534-42. PubMed ID: 19154548
[TBL] [Abstract][Full Text] [Related]
19. The lymphocyte transformation test in the diagnosis of drug hypersensitivity.
Pichler WJ; Tilch J
Allergy; 2004 Aug; 59(8):809-20. PubMed ID: 15230812
[TBL] [Abstract][Full Text] [Related]
20. T cell assessment in allergic drug reactions during the acute phase according to the time of occurrence.
Torres MJ; Mayorga C; Fernández TD; Cornejo-García JA; Antúnez C; Valenzuela M; Del Prado MF; Rodriguez-Pena R; Blanca M
Int J Immunopathol Pharmacol; 2006; 19(1):119-30. PubMed ID: 16569350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
